Susquehanna Maintains Negative on RXO, Raises Price Target to $18

RXO, Inc. Common Stock

RXO, Inc. Common Stock

RXO

0.00

Susquehanna analyst Bascome Majors maintains RXO (NYSE: RXO) with a Negative and raises the price target from $14 to $18.